Clover Health Investments (NASDAQ:CLOV) VP Joseph Frank Oldakowski Sells 20,000 Shares of Stock

Clover Health Investments, Corp. (NASDAQ:CLOVGet Free Report) VP Joseph Frank Oldakowski sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $5.16, for a total value of $103,200.00. Following the completion of the sale, the vice president owned 279,067 shares of the company’s stock, valued at approximately $1,439,985.72. This trade represents a 6.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Joseph Frank Oldakowski also recently made the following trade(s):

  • On Tuesday, June 16th, Joseph Frank Oldakowski sold 12,102 shares of Clover Health Investments stock. The stock was sold at an average price of $4.86, for a total value of $58,815.72.

Clover Health Investments Price Performance

Shares of NASDAQ CLOV opened at $5.10 on Tuesday. The stock has a market capitalization of $2.71 billion, a PE ratio of -101.98 and a beta of 2.47. The business has a fifty day moving average price of $4.43 and a two-hundred day moving average price of $3.57. Clover Health Investments, Corp. has a fifty-two week low of $1.58 and a fifty-two week high of $5.59.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. Clover Health Investments had a negative return on equity of 4.20% and a negative net margin of 0.74%.The firm had revenue of $743.17 million during the quarter, compared to the consensus estimate of $728.27 million.

Hedge Funds Weigh In On Clover Health Investments

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. California State Teachers Retirement System increased its holdings in Clover Health Investments by 387.2% in the second quarter. California State Teachers Retirement System now owns 2,421,577 shares of the company’s stock valued at $12,689,000 after purchasing an additional 1,924,571 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Clover Health Investments in the 2nd quarter valued at about $6,346,000. Tidal Investments LLC acquired a new stake in shares of Clover Health Investments in the second quarter valued at about $2,156,000. Lazard Asset Management LLC acquired a new stake in shares of Clover Health Investments in the first quarter valued at about $309,000. Finally, WINTON GROUP Ltd bought a new position in shares of Clover Health Investments during the second quarter worth about $913,000. 19.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CLOV. UBS Group boosted their price target on Clover Health Investments from $4.75 to $5.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Canaccord Genuity Group increased their target price on shares of Clover Health Investments from $4.20 to $5.50 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Weiss Ratings restated a “sell (d-)” rating on shares of Clover Health Investments in a research note on Wednesday, June 24th. Deutsche Bank Aktiengesellschaft began coverage on shares of Clover Health Investments in a report on Thursday. They set a “buy” rating and a $6.00 price target on the stock. Finally, Wall Street Zen lowered shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clover Health Investments presently has a consensus rating of “Hold” and a consensus target price of $4.75.

View Our Latest Stock Report on Clover Health Investments

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Inc is a healthcare technology and insurance company focused on providing Medicare Advantage plans to eligible Medicare beneficiaries. Its insurance business offers medical coverage and related healthcare benefits through plans available in select counties across the United States.

The company also develops and uses Clover Assistant, a technology platform designed to support physicians with patient information, clinical insights, care recommendations and tools intended to help improve healthcare outcomes.

Featured Articles

Insider Buying and Selling by Quarter for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.